Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C14H17ClO3 |
| Molecular Weight | 268.736 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C2(CCCCCC1=CC=C(Cl)C=C1)CO2
InChI
InChIKey=ACZKTJZXXSHIGF-UHFFFAOYSA-N
InChI=1S/C14H17ClO3/c15-12-7-5-11(6-8-12)4-2-1-3-9-14(10-18-14)13(16)17/h5-8H,1-4,9-10H2,(H,16,17)
| Molecular Formula | C14H17ClO3 |
| Molecular Weight | 268.736 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Clomoxir (POCA, B 807-27) is a potent inhibitor of mitochondrial fatty acid oxidation at the stage of carnitine palmitoyltransferase I (CPT-I). It acts by the tight binding of POCA-CoA to this enzyme. The compound demonstrated hypoketonaemic and hypoglycaemic activities in fasted normal and diabetic rats.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:20:25 GMT 2025
by
admin
on
Mon Mar 31 18:20:25 GMT 2025
|
| Record UNII |
PD884XOZ9F
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C471
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5552
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
CHEMBL1204686
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
C77581
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
88431-47-4
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
DTXSID70869005
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
PD884XOZ9F
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
100000084547
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
54221
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
SUB06727MIG
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |